Correlation Between Mineralys Therapeutics, and Exicure

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Exicure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Exicure into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Exicure, you can compare the effects of market volatilities on Mineralys Therapeutics, and Exicure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Exicure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Exicure.

Diversification Opportunities for Mineralys Therapeutics, and Exicure

-0.04

Correlation Coefficient

Mineralys Therapeutics,  Exicure

Good diversification

The 3 months correlation between Mineralys and Exicure is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Exicure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exicure and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Exicure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exicure has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Exicure go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Exicure

Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 34.07 times less return on investment than Exicure. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 5.46 times less risky than Exicure. It trades about 0.05 of its potential returns per unit of risk. Exicure is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest  194.00  in Exicure on September 1, 2024 and sell it today you would earn a total of  2,755  from holding Exicure or generate 1420.1% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Exicure

Mineralys Therapeutics,

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Exicure

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Exicure are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Exicure reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mineralys Therapeutics, and Exicure

The main advantage of trading using opposite Mineralys Therapeutics, and Exicure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Exicure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will offset losses from the drop in Exicure's long position.

The idea behind Mineralys Therapeutics, Common and Exicure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.